Back to funds
View filing
Affinity Asset Advisors, LLC
hedge fundUpdated 29 days agoManaged by Affinity Asset Advisors, Llc • Latest filing Q2 2026
Portfolio value
$2.2B
Q2 2026
Filings
14
Quarterly 13F history
Top-10 concentration
92.4%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 14 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q1 2023 | $303M |
| Q2 2023 | $286.8M |
| Q3 2023 | $355.5M |
| Q4 2023 | $547.5M |
| Q1 2024 | $807.8M |
| Q2 2024 | $867.5M |
| Q3 2024 | $732.8M |
| Q4 2024 | $746M |
| Q1 2025 | $1B |
| Q2 2025 | $732.2M |
| Q3 2025 | $1.1B |
| Q4 2025 | $1.8B |
| Q1 2026 | $1.9B |
| Q2 2026 | $2.2B |
Top holdings
113 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | R ROIV ROIVANT SCIENCES LTD | $132.7M | 3.75M | 6.00% | — |
| 2 | A APGE APOGEE THERAPEUTICS INC | $131M | 987.0K | 5.92% | — |
| 3 | S SYRE SPYRE THERAPEUTICS INC | $113.6M | 1.28M | 5.13% | — |
| 4 | X XENE XENON PHARMACEUTICALS INC | $96.3M | 1.59M | 4.35% | — |
| 5 | E EQR ERASCA INC | $96.2M | 5.25M | 4.35% | — |
| 6 | I INSM INSMED INC | $69.3M | 650.0K | 3.13% | — |
| 7 | P PRAX PRAXIS PRECISION MEDICINES I | $61.9M | 185.0K | 2.80% | — |
| 8 | A ALKS ALKERMES PLC | $58.9M | 1.13M | 2.66% | — |
| 9 | O ORKA ORUKA THERAPEUTICS INC | $56.2M | 590.0K | 2.54% | — |
| 10 | A ADI ANAPTYSBIO INC | $55.8M | 826.1K | 2.52% | — |
| 11 | ? N/A AVALO THERAPEUTICS INC | $53.6M | 2.90M | 2.42% | — |
| 12 | C CYTK CYTOKINETICS INC | $46.9M | 550.0K | 2.12% | — |
| 13 | R RVMDW REVOLUTION MEDICINES INC | $46.8M | 250.0K | 2.12% | — |
| 14 | A AAVXF ABIVAX SA | $44M | 330.0K | 1.99% | — |
| 15 | ? N/A FIRST TRACKS BIOTHERAPEUTICS | $40.9M | 2.03M | 1.85% | — |
| 16 | D DNTH DIANTHUS THERAPEUTICS INC | $39M | 400.0K | 1.76% | — |
| 17 | ? N/A SUTRO BIOPHARMA INC | $38.9M | 1.17M | 1.76% | — |
| 18 | M MRNA MODERNA INC | $35M | 500.0K | 1.58% | — |
| 19 | ? N/A NUVALENT INC | $34M | 275.0K | 1.53% | — |
| 20 | T TRVI TREVI THERAPEUTICS INC | $33.6M | 1.80M | 1.52% | — |